Gut Microbiome Profiles Are Associated With Type 2 Diabetes in Urban Africans
JournalFrontiers in Cellular and Infection Microbiology
PublisherFrontiers Media S.A.
MetadataShow full item record
AbstractGut dysbiosis has been associated with several disease outcomes including diabetes in human populations. Currently, there are no studies of the gut microbiome composition in relation to type 2 diabetes (T2D) in Africans. Here, we describe the profile of the gut microbiome in non-diabetic adults (controls) and investigate the association between gut microbiota and T2D in urban West Africans. Gut microbiota composition was determined in 291 Nigerians (98 cases, 193 controls) using fecal 16S V4 rRNA gene sequencing done on the Illumina MiSeq platform. Data analysis of operational taxonomic units (OTU) was conducted to describe microbiome composition and identify differences between T2D and controls. The most abundant phyla were Firmicutes, Actinobacteria, and Bacteroidetes. Clostridiaceae, and Peptostreptococcaceaea were significantly lower in cases than controls (p < 0.001). Feature selection analysis identified a panel of 18 OTUs enriched in cases that included Desulfovibrio piger, Prevotella, Peptostreptococcus, and Eubacterium. A panel of 17 OTUs that was enriched in the controls included Collinsella, Ruminococcus lactaris, Anaerostipes, and Clostridium. OTUs with strain-level annotation showing the largest fold-change included Cellulosilyticum ruminicola (log2FC = −3.1; p = 4.2 × 10−5), Clostridium paraputrificum (log2FC = −2.5; p = 0.005), and Clostridium butyricum (log2FC = −1.76; p = 0.01), all lower in cases. These findings are notable because supplementation with Clostridium butyricum and Desulfovibrio piger has been shown to improve hyperglycemia and reduce insulin resistance in murine models. This first investigation of gut microbiome and diabetes in urban Africans shows that T2D is associated with compositional changes in gut microbiota highlighting the possibility of developing strategies to improve glucose control by modifying bacterial composition in the gut. Copyright 2020 The Authors.
Sponsorsunding. The Africa America Diabetes Mellitus (AADM) study was supported by NIH Grant No. 3T37TW00041-03S2 from the National Institute on Minority Health and Health Disparities.
Identifier to cite or link to this itemhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85081672337&doi=10.3389%2ffcimb.2020.00063&partnerID=40&md5=d9e80f2c34759218ad19e195eb7bcf1e; http://hdl.handle.net/10713/12378
- Gestational diabetes is associated with change in the gut microbiota composition in third trimester of pregnancy and postpartum.
- Authors: Crusell MKW, Hansen TH, Nielsen T, Allin KH, Rühlemann MC, Damm P, Vestergaard H, Rørbye C, Jørgensen NR, Christiansen OB, Heinsen FA, Franke A, Hansen T, Lauenborg J, Pedersen O
- Issue date: 2018 May 15
- Gut microbiota in Mexican patients with common variable immunodeficiency.
- Authors: Franco-Esquivias AP, Peña CG, Torres-Lozano C, Vaca-Paniagua F, Díaz-Velásquez C, Ortega-Cisneros M, Quintero-Ramos A
- Issue date: 2019
- The Association of Targeted Gut Microbiota with Body Composition in Type 2 Diabetes Mellitus.
- Authors: Hung WC, Hung WW, Tsai HJ, Chang CC, Chiu YW, Hwang SJ, Kuo MC, Chen SC, Dai CY, Tsai YC
- Issue date: 2021
- Microbiota bacteriana intestinal en pacientes mexicanos con inmunodeficiencia común variable.
- Authors: Franco-Esquivias AP, García-De la Peña C, Torres-Lozano C, Vaca-Paniagua F, Díaz-Velásquez C, Ortega-Cisneros M, Quintero-Ramos A
- Issue date: 2019
- Baseline gut microbiome composition predicts metformin therapy short-term efficacy in newly diagnosed type 2 diabetes patients.
- Authors: Elbere I, Silamikelis I, Dindune II, Kalnina I, Ustinova M, Zaharenko L, Silamikele L, Rovite V, Gudra D, Konrade I, Sokolovska J, Pirags V, Klovins J
- Issue date: 2020